非洲的穿皮冠状动脉干预:相关结果的系统审查
Chibuike F Obi1, Collins C Okeke2, Augusta U Onyema3
1General Internal Medicine, Fairfield General Hospital - Northern Care Alliance NHS Foundation Trust, Manchester, GBR.
Cureus
|August 25, 2025
概括
穿皮冠状动脉干预 (PCI) 结果显示,与资源较高的环境相比,死亡率和并发症率更高. 解决心血管保健中的系统性缺陷对于改善患者结果至关重要.
科学领域:
- 心脏病学
- 公共卫生
- 卫生系统研究
背景情况:
- 穿皮冠状动脉干预 (PCI) 对于治疗冠状动脉疾病至关重要.
- 在非洲,PCI的使用正在增加,因此需要对其在非洲大陆的临床结果进行评估.
研究的目的:
- 审查和报告非洲冠心病患者PCI的临床结果.
- 确定非洲PCI相关的常见并发症和死亡率.
主要方法:
- 通过PubMed,EMBASE和AJOL的搜索,使用PRISMA指南进行了系统审查.
- 来自九个非洲国家的31篇文章,涉及10701个PCI程序,被纳入定性分析.
主要成果:
- 总体死亡率为4. 9%,住院死亡率为4. 7%. 在17. 8%的病例中报告了重大心血管不良事件 (MACE).
- 常见的并发症包括心力衰竭 (19. 1%),心律失常 (9. 1%) 和再血管化 (8. 9%). 在78. 2%的患者中实现了术后TIMI流量III级.
- ST升高心肌梗塞 (STEMI) 是PCI的主要征兆,突出了反应性医疗保健方法.
结论:
- 非洲的PCI结果,包括死亡率和并发症率,高于资源较高的国家.
- 在急性和慢性心血管疾病护理方面,高的并发症负担和系统性缺口有助于这些结果.
- 优先考虑环境敏感的指导方针,能力建设和护理连续性对于改善结果和减少健康不平等至关重要.
相关概念视频
Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Peripheral Artery Disease III: Interprofessional Care
29
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
29
Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30


